Small P, Keith PK, Kim H. Allergic rhinitis Allergy Asthma. Clin Immunol. 2018;14:51 (aacijournal.biomedcentral.com).

Google Scholar 

Yamada T, Saito H, Fujieda S. Present state of Japanese cedar pollinosis: the national affliction. J Allergy Clin Immunol. 2014;133:632-9.e5.

PubMed  Article  Google Scholar 

Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, Muraro A, Postma MJ, Kocks JWH, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Rev Pharmacoecon Outcomes Res. 2020;20:437–53.

PubMed  Article  Google Scholar 

Jutel M, Kosowska A, Smolinska S. Allergen immunotherapy: past, present, and future allergy asthma. Immunol Res. 2016;8:191–7 (synapse.koreamed.org).

CAS  Google Scholar 

Masuyama K, Matsuoka T, Kamijo A. Current status of sublingual immunotherapy for allergic rhinitis in Japan. Allergol Int. 2018;67:320–5 (jstage.jst.go.jp).

CAS  PubMed  Article  Google Scholar 

Pitsios C, Demoly P, Bilò MB, Gerth van Wijk R, Pfaar O, Sturm GJ, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015;70:897–909.

CAS  PubMed  Article  Google Scholar 

Pitsios C, Tsoumani M, Bilò MB, Sturm GJ, Rodríguez Del Río P, Gawlik R, et al. Contraindications to immunotherapy: a global approach. Clin Transl Allergy. 2019;9:45.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Linneberg A, Madsen F, Skaaby T. Allergen-specific immunotherapy and risk of autoimmune disease. Curr Opin Allergy Clin Immunol. 2012;12:635–9.

CAS  PubMed  Article  Google Scholar 

Linneberg A, Jacobsen RK, Jespersen L, Abildstrøm SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. J Allergy Clin Immunol. 2012;129:413–9.

PubMed  Article  Google Scholar 

Bozek A, Kozłowska R, Jarzab J. The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control Study. Int Arch Allergy Immunol. 2014;163:307–12.

CAS  PubMed  Article  Google Scholar 

Iemoli E, Borgonovo L, Fusi A, Magni C, Ricci ED, Rizzardini G, et al. Sublingual allergen immunotherapy in HIV-positive patients. Allergy. 2016;71:412–5.

CAS  PubMed  Article  Google Scholar 

Rodríguez del Rio P, Pitsios C, Tsoumani M, Pfaar O, Paraskevopoulos G, Gawlik R, et al. Physicians’ experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey. Ann Allergy Asthma Immunol. 2017;118:621–8.

PubMed  Article  Google Scholar 

Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology. 2003;42:244–57.

CAS  PubMed  Article  Google Scholar 

van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41:1845–50.

PubMed  Article  Google Scholar 

Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827–32.

CAS  PubMed  Article  Google Scholar 

Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5.

CAS  PubMed  Google Scholar 

Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69:1103–9.

PubMed  Article  Google Scholar 

Okuda M, Ohkubo K, Goto M, Okamoto H, Konno A, Baba K, et al. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol. 2005;125:736–44.

CAS  PubMed  Article  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

CAS  PubMed  Article  Google Scholar 

U.S. Department Of Health And Human Services. 2017 Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 2022 Apr 22

Fiorillo A, Fonacier L, Diola C. Safety of allergenic immunotherapy in systemic lupus erythematosus. J Allergy Clin Immunol. 2006;117:S264.

Article  Google Scholar 

Ghoreschi K, Fischer J, Biedermann T. Manifestation of rheumatoid arthritis during subcutaneous allergen-specific immunotherapy with bee venom. J Allergy Clin Immunol. 2012. https://doi.org/10.1016/j.jaci.2012.08.052.

Article  PubMed  Google Scholar 

Mukherjee S, Samajdar SS, Basu K, Moitra S, Tripath SK. Patient on allergen immunotherapy developed systemic lupus erythematosus?– A clinico-pharmacological look out. IP International Journal of Orthopaedic Rheumatology. 2022;7:90–2 (Innovative Publication Pvt Ltd).

Article  Google Scholar 

Turkcapar N, Kinikli G, Sak SD, Duman M. Specific immunotherapy-induced Sjögren’s syndrome. Rheumatol Int. 2005;26:182–4.

CAS  PubMed  Article  Google Scholar 

Phanuphak P, Kohler PF. Onset of polyarteritis nodosa during allergic hyposensitization treatment. Am J Med. 1980;68:479–85.

CAS  PubMed  Article  Google Scholar 

Taylor RJ. Hypersensitivity vasculitis occurring in a patient receiving immunotherapy. J Allergy Clin Immunol. 1991;87:889–90.

CAS  PubMed  Article  Google Scholar 

Codina R, Crenshaw RC, Lockey RF. Considerations about pollen used for the production of allergen extracts. J Allergy Clin Immunol Pract. 2015;3:676–82.

PubMed  Article  Google Scholar 

Terada T, Matsuda M, Inaba M, Hamaguchi J, Takemoto N, Kikuoka Y, et al. Sublingual immunotherapy for 4 years increased the number of Foxp3+ Treg cells, which correlated with clinical effects. Inflamm Res. 2021;70:581–9.

CAS  PubMed  Article  Google Scholar 

Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol Elsevier. 1996;97:1356–65.

CAS  Article  Google Scholar 

Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol. 2007;120:707–13.

CAS  PubMed  Article  Google Scholar 

Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006;6:761–71.

PubMed  Article  CAS  Google Scholar 

Chemin K, Gerstner C, Malmström V. Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation—Lessons From Rheumatoid Arthritis. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.00353 (frontiersin.org).

Article  PubMed  PubMed Central  Google Scholar 

Lee EJ, Lilja S, Li X, Schäfer S, Zhang H, Benson M. Bulk and single cell transcriptomic data indicate that a dichotomy between inflammatory pathways in peripheral blood and arthritic joints complicates biomarker discovery. Cytokine. 2020;127:154960.

CAS  PubMed  Article  Google Scholar 

Chodisetti SB, Fike AJ, Domeier PP, Singh H, Choi NM, Corradetti C, et al. Type II but not type I IFN signaling is indispensable for TLR7-promoted development of autoreactive B cells and systemic autoimmunity. J Immunol. 2020;204:796–809.

CAS  PubMed  Article  Google Scholar 

Machold KP, Smolen JS. Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol. 1990;17:831–2.

CAS  PubMed  Google Scholar 

Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, et al. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol. 1992;65:70–4.

CAS  PubMed  Article  Google Scholar 

Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, et al. Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma canadian urologic oncology group. N Engl J Med. 1998;338:1265–71.

CAS  PubMed  Article  Google Scholar 

Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125–33 (Massachusetts Medical Society).

CAS  PubMed  Article  Google Scholar 

Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin Infect Dis Oxford Academic. 2004;39:692–9.

CAS  Article  Google Scholar 

Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, et al. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. 2015;166:177–88.

CAS  PubMed  Article  Google Scholar 

Yonekura S, Gotoh M, Kaneko S, Kanazawa K, Takeuji Y, Okubo K, et al. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: evaluation of a phase II/III trial over three pollen dispersal seasons. Allergol Int. 2019;68:494–505.

PubMed  Article